nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—Methocarbamol—CA1—esophageal cancer	0.0254	0.674	CrCbGaD
Felbamate—Lacosamide—CA1—esophageal cancer	0.00698	0.186	CrCbGaD
Felbamate—Lacosamide—CA2—esophageal cancer	0.00529	0.141	CrCbGaD
Felbamate—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00329	0.00498	CcSEcCtD
Felbamate—Paralysis—Methotrexate—esophageal cancer	0.00323	0.00489	CcSEcCtD
Felbamate—Haematemesis—Methotrexate—esophageal cancer	0.00323	0.00489	CcSEcCtD
Felbamate—Renal failure acute—Cisplatin—esophageal cancer	0.00322	0.00487	CcSEcCtD
Felbamate—Dysarthria—Capecitabine—esophageal cancer	0.00319	0.00483	CcSEcCtD
Felbamate—Hearing impaired—Capecitabine—esophageal cancer	0.00317	0.0048	CcSEcCtD
Felbamate—Gait disturbance—Capecitabine—esophageal cancer	0.00309	0.00468	CcSEcCtD
Felbamate—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00307	0.00465	CcSEcCtD
Felbamate—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00302	0.00457	CcSEcCtD
Felbamate—Hiccups—Capecitabine—esophageal cancer	0.00302	0.00457	CcSEcCtD
Felbamate—Stupor—Methotrexate—esophageal cancer	0.00301	0.00455	CcSEcCtD
Felbamate—Hyponatraemia—Cisplatin—esophageal cancer	0.00298	0.00452	CcSEcCtD
Felbamate—Pleural effusion—Methotrexate—esophageal cancer	0.00293	0.00444	CcSEcCtD
Felbamate—Influenza like illness—Capecitabine—esophageal cancer	0.00293	0.00444	CcSEcCtD
Felbamate—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00291	0.00441	CcSEcCtD
Felbamate—Urinary incontinence—Capecitabine—esophageal cancer	0.00291	0.00441	CcSEcCtD
Felbamate—Face oedema—Cisplatin—esophageal cancer	0.00287	0.00434	CcSEcCtD
Felbamate—Necrosis—Methotrexate—esophageal cancer	0.00286	0.00433	CcSEcCtD
Felbamate—Dehydration—Cisplatin—esophageal cancer	0.00276	0.00418	CcSEcCtD
Felbamate—Oesophagitis—Capecitabine—esophageal cancer	0.00275	0.00417	CcSEcCtD
Felbamate—Mouth ulceration—Capecitabine—esophageal cancer	0.00273	0.00413	CcSEcCtD
Felbamate—Neoplasm—Capecitabine—esophageal cancer	0.00273	0.00413	CcSEcCtD
Felbamate—Hypokalaemia—Cisplatin—esophageal cancer	0.0027	0.00409	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00267	0.00405	CcSEcCtD
Felbamate—Abnormal vision—Capecitabine—esophageal cancer	0.00263	0.00398	CcSEcCtD
Felbamate—Sepsis—Capecitabine—esophageal cancer	0.00262	0.00396	CcSEcCtD
Felbamate—Mental disability—Capecitabine—esophageal cancer	0.00262	0.00396	CcSEcCtD
Felbamate—Thrombophlebitis—Capecitabine—esophageal cancer	0.00253	0.00383	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00252	0.00381	CcSEcCtD
Felbamate—Pancreatitis—Cisplatin—esophageal cancer	0.00252	0.00381	CcSEcCtD
Felbamate—Vascular purpura—Capecitabine—esophageal cancer	0.00245	0.00371	CcSEcCtD
Felbamate—Pancytopenia—Cisplatin—esophageal cancer	0.00244	0.00369	CcSEcCtD
Felbamate—Glossitis—Methotrexate—esophageal cancer	0.00244	0.00369	CcSEcCtD
Felbamate—Hepatic failure—Capecitabine—esophageal cancer	0.00244	0.00369	CcSEcCtD
Felbamate—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00242	0.00367	CcSEcCtD
Felbamate—Dysarthria—Methotrexate—esophageal cancer	0.00237	0.00359	CcSEcCtD
Felbamate—Renal failure acute—Capecitabine—esophageal cancer	0.00237	0.00359	CcSEcCtD
Felbamate—Increased appetite—Capecitabine—esophageal cancer	0.00233	0.00353	CcSEcCtD
Felbamate—Atrial fibrillation—Capecitabine—esophageal cancer	0.00231	0.0035	CcSEcCtD
Felbamate—Renal impairment—Capecitabine—esophageal cancer	0.0023	0.00348	CcSEcCtD
Felbamate—Vasculitis—Methotrexate—esophageal cancer	0.0023	0.00348	CcSEcCtD
Felbamate—Dermatitis bullous—Capecitabine—esophageal cancer	0.00229	0.00347	CcSEcCtD
Felbamate—Respiratory failure—Methotrexate—esophageal cancer	0.00229	0.00346	CcSEcCtD
Felbamate—Purpura—Capecitabine—esophageal cancer	0.00227	0.00344	CcSEcCtD
Felbamate—Cardiac failure—Capecitabine—esophageal cancer	0.00224	0.0034	CcSEcCtD
Felbamate—Conjunctivitis—Cisplatin—esophageal cancer	0.00222	0.00337	CcSEcCtD
Felbamate—Hyponatraemia—Capecitabine—esophageal cancer	0.0022	0.00333	CcSEcCtD
Felbamate—Diplopia—Capecitabine—esophageal cancer	0.00219	0.00332	CcSEcCtD
Felbamate—Osteoarthritis—Capecitabine—esophageal cancer	0.00219	0.00332	CcSEcCtD
Felbamate—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00217	0.00328	CcSEcCtD
Felbamate—Migraine—Capecitabine—esophageal cancer	0.00215	0.00326	CcSEcCtD
Felbamate—Face oedema—Capecitabine—esophageal cancer	0.00211	0.0032	CcSEcCtD
Felbamate—Aplastic anaemia—Methotrexate—esophageal cancer	0.00211	0.00319	CcSEcCtD
Felbamate—Bradycardia—Cisplatin—esophageal cancer	0.00209	0.00317	CcSEcCtD
Felbamate—Cardiac arrest—Capecitabine—esophageal cancer	0.00208	0.00315	CcSEcCtD
Felbamate—Urinary retention—Capecitabine—esophageal cancer	0.00208	0.00315	CcSEcCtD
Felbamate—Mood swings—Capecitabine—esophageal cancer	0.00207	0.00314	CcSEcCtD
Felbamate—Ataxia—Capecitabine—esophageal cancer	0.00206	0.00312	CcSEcCtD
Felbamate—Coma—Methotrexate—esophageal cancer	0.00205	0.00311	CcSEcCtD
Felbamate—Dehydration—Capecitabine—esophageal cancer	0.00204	0.00308	CcSEcCtD
Felbamate—Mouth ulceration—Methotrexate—esophageal cancer	0.00203	0.00307	CcSEcCtD
Felbamate—Neoplasm—Methotrexate—esophageal cancer	0.00203	0.00307	CcSEcCtD
Felbamate—Hypokalaemia—Capecitabine—esophageal cancer	0.00199	0.00302	CcSEcCtD
Felbamate—Visual impairment—Cisplatin—esophageal cancer	0.00198	0.003	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00197	0.00299	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00197	0.00299	CcSEcCtD
Felbamate—Sepsis—Methotrexate—esophageal cancer	0.00195	0.00295	CcSEcCtD
Felbamate—Gastritis—Capecitabine—esophageal cancer	0.00194	0.00293	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00193	0.00292	CcSEcCtD
Felbamate—Muscular weakness—Capecitabine—esophageal cancer	0.00193	0.00292	CcSEcCtD
Felbamate—Lymphadenopathy—Methotrexate—esophageal cancer	0.00191	0.00289	CcSEcCtD
Felbamate—Flushing—Cisplatin—esophageal cancer	0.00191	0.00289	CcSEcCtD
Felbamate—Dysphagia—Capecitabine—esophageal cancer	0.00189	0.00287	CcSEcCtD
Felbamate—Asthma—Capecitabine—esophageal cancer	0.00189	0.00287	CcSEcCtD
Felbamate—Thrombophlebitis—Methotrexate—esophageal cancer	0.00188	0.00285	CcSEcCtD
Felbamate—Alopecia—Cisplatin—esophageal cancer	0.00181	0.00275	CcSEcCtD
Felbamate—Hepatic failure—Methotrexate—esophageal cancer	0.00181	0.00275	CcSEcCtD
Felbamate—Pancytopenia—Capecitabine—esophageal cancer	0.0018	0.00272	CcSEcCtD
Felbamate—Dysuria—Capecitabine—esophageal cancer	0.00177	0.00268	CcSEcCtD
Felbamate—Renal failure acute—Methotrexate—esophageal cancer	0.00176	0.00267	CcSEcCtD
Felbamate—Flatulence—Cisplatin—esophageal cancer	0.00176	0.00267	CcSEcCtD
Felbamate—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00176	0.00266	CcSEcCtD
Felbamate—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00173	0.00262	CcSEcCtD
Felbamate—Weight increased—Capecitabine—esophageal cancer	0.00172	0.00261	CcSEcCtD
Felbamate—Weight decreased—Capecitabine—esophageal cancer	0.00171	0.00259	CcSEcCtD
Felbamate—Hyperglycaemia—Capecitabine—esophageal cancer	0.00171	0.00258	CcSEcCtD
Felbamate—Pneumonia—Capecitabine—esophageal cancer	0.0017	0.00257	CcSEcCtD
Felbamate—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00168	0.00255	CcSEcCtD
Felbamate—Depression—Capecitabine—esophageal cancer	0.00168	0.00255	CcSEcCtD
Felbamate—Tremor—Cisplatin—esophageal cancer	0.00168	0.00254	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00167	0.00253	CcSEcCtD
Felbamate—Ill-defined disorder—Cisplatin—esophageal cancer	0.00166	0.00251	CcSEcCtD
Felbamate—Anaemia—Cisplatin—esophageal cancer	0.00165	0.0025	CcSEcCtD
Felbamate—Jaundice—Capecitabine—esophageal cancer	0.00164	0.00249	CcSEcCtD
Felbamate—Conjunctivitis—Capecitabine—esophageal cancer	0.00164	0.00248	CcSEcCtD
Felbamate—Urinary tract infection—Capecitabine—esophageal cancer	0.00164	0.00248	CcSEcCtD
Felbamate—Osteoarthritis—Methotrexate—esophageal cancer	0.00163	0.00247	CcSEcCtD
Felbamate—Malaise—Cisplatin—esophageal cancer	0.00161	0.00244	CcSEcCtD
Felbamate—Haematuria—Capecitabine—esophageal cancer	0.00161	0.00244	CcSEcCtD
Felbamate—Leukopenia—Cisplatin—esophageal cancer	0.0016	0.00242	CcSEcCtD
Felbamate—Epistaxis—Capecitabine—esophageal cancer	0.00159	0.00241	CcSEcCtD
Felbamate—CYP2C19—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00158	0.00521	CbGpPWpGaD
Felbamate—Agranulocytosis—Capecitabine—esophageal cancer	0.00157	0.00238	CcSEcCtD
Felbamate—Mood swings—Methotrexate—esophageal cancer	0.00154	0.00234	CcSEcCtD
Felbamate—Bradycardia—Capecitabine—esophageal cancer	0.00154	0.00233	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—CASP8—esophageal cancer	0.00154	0.00509	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00153	0.00507	CbGpPWpGaD
Felbamate—Ataxia—Methotrexate—esophageal cancer	0.00153	0.00232	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00152	0.00504	CbGpPWpGaD
Felbamate—Myalgia—Cisplatin—esophageal cancer	0.00152	0.00231	CcSEcCtD
Felbamate—Haemoglobin—Capecitabine—esophageal cancer	0.00152	0.00231	CcSEcCtD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00152	0.00503	CbGpPWpGaD
Felbamate—Rhinitis—Capecitabine—esophageal cancer	0.00152	0.0023	CcSEcCtD
Felbamate—Anxiety—Cisplatin—esophageal cancer	0.00152	0.0023	CcSEcCtD
Felbamate—Haemorrhage—Capecitabine—esophageal cancer	0.00151	0.00229	CcSEcCtD
Felbamate—Hepatitis—Capecitabine—esophageal cancer	0.00151	0.00229	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00151	0.00501	CbGpPWpGaD
Felbamate—GRIN2B—Reelin signaling pathway—PIK3CA—esophageal cancer	0.0015	0.00498	CbGpPWpGaD
Felbamate—Discomfort—Cisplatin—esophageal cancer	0.0015	0.00228	CcSEcCtD
Felbamate—Pharyngitis—Capecitabine—esophageal cancer	0.0015	0.00228	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00149	0.00492	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00148	0.0049	CbGpPWpGaD
Felbamate—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00147	0.00222	CcSEcCtD
Felbamate—Oedema—Cisplatin—esophageal cancer	0.00146	0.00221	CcSEcCtD
Felbamate—Anaphylactic shock—Cisplatin—esophageal cancer	0.00146	0.00221	CcSEcCtD
Felbamate—Visual impairment—Capecitabine—esophageal cancer	0.00146	0.00221	CcSEcCtD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00145	0.0048	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00145	0.0048	CbGpPWpGaD
Felbamate—Infection—Cisplatin—esophageal cancer	0.00145	0.0022	CcSEcCtD
Felbamate—Erythema multiforme—Capecitabine—esophageal cancer	0.00143	0.00217	CcSEcCtD
Felbamate—Thrombocytopenia—Cisplatin—esophageal cancer	0.00143	0.00216	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—GNG7—esophageal cancer	0.00143	0.00473	CbGpPWpGaD
Felbamate—Tachycardia—Cisplatin—esophageal cancer	0.00142	0.00216	CcSEcCtD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00142	0.00468	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00141	0.00467	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—PFN1—esophageal cancer	0.00141	0.00467	CbGpPWpGaD
Felbamate—Hyperhidrosis—Cisplatin—esophageal cancer	0.00141	0.00214	CcSEcCtD
Felbamate—Asthma—Methotrexate—esophageal cancer	0.00141	0.00213	CcSEcCtD
Felbamate—Flushing—Capecitabine—esophageal cancer	0.00141	0.00213	CcSEcCtD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.0014	0.00462	CbGpPWpGaD
Felbamate—Eosinophilia—Methotrexate—esophageal cancer	0.00139	0.00211	CcSEcCtD
Felbamate—Anorexia—Cisplatin—esophageal cancer	0.00139	0.00211	CcSEcCtD
Felbamate—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00139	0.00459	CbGpPWpGaD
Felbamate—Pancreatitis—Methotrexate—esophageal cancer	0.00138	0.00209	CcSEcCtD
Felbamate—Hypotension—Cisplatin—esophageal cancer	0.00136	0.00207	CcSEcCtD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00136	0.0045	CbGpPWpGaD
Felbamate—Chills—Capecitabine—esophageal cancer	0.00136	0.00206	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—ALDH2—esophageal cancer	0.00134	0.00443	CbGpPWpGaD
Felbamate—Alopecia—Capecitabine—esophageal cancer	0.00134	0.00203	CcSEcCtD
Felbamate—Pancytopenia—Methotrexate—esophageal cancer	0.00134	0.00203	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00134	0.00442	CbGpPWpGaD
Felbamate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00133	0.00201	CcSEcCtD
Felbamate—GRIN2B—EPH-Ephrin signaling—KDR—esophageal cancer	0.00133	0.00439	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00133	0.00439	CbGpPWpGaD
Felbamate—Dysuria—Methotrexate—esophageal cancer	0.00132	0.00199	CcSEcCtD
Felbamate—Paraesthesia—Cisplatin—esophageal cancer	0.00131	0.00198	CcSEcCtD
Felbamate—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00131	0.00198	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—CASP8—esophageal cancer	0.00131	0.00433	CbGpPWpGaD
Felbamate—Dyspnoea—Cisplatin—esophageal cancer	0.0013	0.00197	CcSEcCtD
Felbamate—Flatulence—Capecitabine—esophageal cancer	0.0013	0.00197	CcSEcCtD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00129	0.00428	CbGpPWpGaD
Felbamate—Dysgeusia—Capecitabine—esophageal cancer	0.00129	0.00196	CcSEcCtD
Felbamate—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00129	0.00195	CcSEcCtD
Felbamate—Decreased appetite—Cisplatin—esophageal cancer	0.00127	0.00192	CcSEcCtD
Felbamate—Pneumonia—Methotrexate—esophageal cancer	0.00126	0.00191	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—PIK3CA—esophageal cancer	0.00126	0.00417	CbGpPWpGaD
Felbamate—Depression—Methotrexate—esophageal cancer	0.00125	0.0019	CcSEcCtD
Felbamate—Pain—Cisplatin—esophageal cancer	0.00125	0.00189	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00124	0.00189	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00124	0.00411	CbGpPWpGaD
Felbamate—Tremor—Capecitabine—esophageal cancer	0.00123	0.00187	CcSEcCtD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00123	0.00406	CbGpPWpGaD
Felbamate—Ill-defined disorder—Capecitabine—esophageal cancer	0.00122	0.00185	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00122	0.00404	CbGpPWpGaD
Felbamate—Conjunctivitis—Methotrexate—esophageal cancer	0.00122	0.00185	CcSEcCtD
Felbamate—Anaemia—Capecitabine—esophageal cancer	0.00122	0.00185	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—GNG7—esophageal cancer	0.00121	0.00402	CbGpPWpGaD
Felbamate—Sweating—Methotrexate—esophageal cancer	0.0012	0.00182	CcSEcCtD
Felbamate—Feeling abnormal—Cisplatin—esophageal cancer	0.0012	0.00182	CcSEcCtD
Felbamate—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.0012	0.00397	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.0012	0.00396	CbGpPWpGaD
Felbamate—Haematuria—Methotrexate—esophageal cancer	0.0012	0.00181	CcSEcCtD
Felbamate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.0012	0.00396	CbGpPWpGaD
Felbamate—Malaise—Capecitabine—esophageal cancer	0.00119	0.0018	CcSEcCtD
Felbamate—Epistaxis—Methotrexate—esophageal cancer	0.00118	0.00179	CcSEcCtD
Felbamate—Leukopenia—Capecitabine—esophageal cancer	0.00118	0.00179	CcSEcCtD
Felbamate—Agranulocytosis—Methotrexate—esophageal cancer	0.00117	0.00177	CcSEcCtD
Felbamate—Palpitations—Capecitabine—esophageal cancer	0.00116	0.00176	CcSEcCtD
Felbamate—Body temperature increased—Cisplatin—esophageal cancer	0.00115	0.00175	CcSEcCtD
Felbamate—Cough—Capecitabine—esophageal cancer	0.00115	0.00174	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00115	0.0038	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—CFL1—esophageal cancer	0.00114	0.00378	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00114	0.00378	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—ALDH2—esophageal cancer	0.00114	0.00377	CbGpPWpGaD
Felbamate—Hypertension—Capecitabine—esophageal cancer	0.00114	0.00172	CcSEcCtD
Felbamate—Haemoglobin—Methotrexate—esophageal cancer	0.00113	0.00172	CcSEcCtD
Felbamate—Haemorrhage—Methotrexate—esophageal cancer	0.00113	0.00171	CcSEcCtD
Felbamate—Hepatitis—Methotrexate—esophageal cancer	0.00113	0.00171	CcSEcCtD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00113	0.00373	CbGpPWpGaD
Felbamate—Chest pain—Capecitabine—esophageal cancer	0.00112	0.0017	CcSEcCtD
Felbamate—Myalgia—Capecitabine—esophageal cancer	0.00112	0.0017	CcSEcCtD
Felbamate—Arthralgia—Capecitabine—esophageal cancer	0.00112	0.0017	CcSEcCtD
Felbamate—Pharyngitis—Methotrexate—esophageal cancer	0.00112	0.00169	CcSEcCtD
Felbamate—Anxiety—Capecitabine—esophageal cancer	0.00112	0.00169	CcSEcCtD
Felbamate—Discomfort—Capecitabine—esophageal cancer	0.00111	0.00168	CcSEcCtD
Felbamate—Dry mouth—Capecitabine—esophageal cancer	0.0011	0.00166	CcSEcCtD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00109	0.00361	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00109	0.0036	CbGpPWpGaD
Felbamate—Visual impairment—Methotrexate—esophageal cancer	0.00109	0.00165	CcSEcCtD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00109	0.00359	CbGpPWpGaD
Felbamate—Confusional state—Capecitabine—esophageal cancer	0.00108	0.00164	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00108	0.00357	CbGpPWpGaD
Felbamate—Oedema—Capecitabine—esophageal cancer	0.00108	0.00163	CcSEcCtD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00107	0.00355	CbGpPWpGaD
Felbamate—Infection—Capecitabine—esophageal cancer	0.00107	0.00162	CcSEcCtD
Felbamate—Erythema multiforme—Methotrexate—esophageal cancer	0.00107	0.00161	CcSEcCtD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00106	0.0035	CbGpPWpGaD
Felbamate—Thrombocytopenia—Capecitabine—esophageal cancer	0.00105	0.0016	CcSEcCtD
Felbamate—Tachycardia—Capecitabine—esophageal cancer	0.00105	0.00159	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—ADH7—esophageal cancer	0.00105	0.00347	CbGpPWpGaD
Felbamate—Asthenia—Cisplatin—esophageal cancer	0.00105	0.00159	CcSEcCtD
Felbamate—Hyperhidrosis—Capecitabine—esophageal cancer	0.00104	0.00158	CcSEcCtD
Felbamate—Anorexia—Capecitabine—esophageal cancer	0.00103	0.00155	CcSEcCtD
Felbamate—CYP2C19—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00102	0.00337	CbGpPWpGaD
Felbamate—Chills—Methotrexate—esophageal cancer	0.00101	0.00153	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—PFN1—esophageal cancer	0.00101	0.00333	CbGpPWpGaD
Felbamate—Hypotension—Capecitabine—esophageal cancer	0.00101	0.00152	CcSEcCtD
Felbamate—Diarrhoea—Cisplatin—esophageal cancer	0.000998	0.00151	CcSEcCtD
Felbamate—Alopecia—Methotrexate—esophageal cancer	0.000996	0.00151	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00098	0.00148	CcSEcCtD
Felbamate—Insomnia—Capecitabine—esophageal cancer	0.000973	0.00147	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—ACTB—esophageal cancer	0.000972	0.00322	CbGpPWpGaD
Felbamate—Paraesthesia—Capecitabine—esophageal cancer	0.000966	0.00146	CcSEcCtD
Felbamate—Dysgeusia—Methotrexate—esophageal cancer	0.000961	0.00146	CcSEcCtD
Felbamate—Dyspnoea—Capecitabine—esophageal cancer	0.000959	0.00145	CcSEcCtD
Felbamate—Dyspepsia—Capecitabine—esophageal cancer	0.000947	0.00143	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000942	0.00312	CbGpPWpGaD
Felbamate—Decreased appetite—Capecitabine—esophageal cancer	0.000935	0.00142	CcSEcCtD
Felbamate—Vomiting—Cisplatin—esophageal cancer	0.000928	0.00141	CcSEcCtD
Felbamate—Fatigue—Capecitabine—esophageal cancer	0.000927	0.0014	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000925	0.00306	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000922	0.00305	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—ADH1B—esophageal cancer	0.00092	0.00305	CbGpPWpGaD
Felbamate—Rash—Cisplatin—esophageal cancer	0.00092	0.00139	CcSEcCtD
Felbamate—Pain—Capecitabine—esophageal cancer	0.00092	0.00139	CcSEcCtD
Felbamate—Constipation—Capecitabine—esophageal cancer	0.00092	0.00139	CcSEcCtD
Felbamate—Dermatitis—Cisplatin—esophageal cancer	0.000919	0.00139	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000917	0.00303	CbGpPWpGaD
Felbamate—Ill-defined disorder—Methotrexate—esophageal cancer	0.00091	0.00138	CcSEcCtD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00091	0.00301	CbGpPWpGaD
Felbamate—Anaemia—Methotrexate—esophageal cancer	0.000907	0.00137	CcSEcCtD
Felbamate—Feeling abnormal—Capecitabine—esophageal cancer	0.000886	0.00134	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000885	0.00293	CbGpPWpGaD
Felbamate—Malaise—Methotrexate—esophageal cancer	0.000885	0.00134	CcSEcCtD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00088	0.00291	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00088	0.00133	CcSEcCtD
Felbamate—Leukopenia—Methotrexate—esophageal cancer	0.000878	0.00133	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00087	0.00288	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000869	0.00287	CbGpPWpGaD
Felbamate—Nausea—Cisplatin—esophageal cancer	0.000867	0.00131	CcSEcCtD
Felbamate—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000864	0.00286	CbGpPWpGaD
Felbamate—Cough—Methotrexate—esophageal cancer	0.000856	0.0013	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—CYP26A1—esophageal cancer	0.000856	0.00283	CbGpPWpGaD
Felbamate—Urticaria—Capecitabine—esophageal cancer	0.000855	0.00129	CcSEcCtD
Felbamate—Abdominal pain—Capecitabine—esophageal cancer	0.00085	0.00129	CcSEcCtD
Felbamate—Body temperature increased—Capecitabine—esophageal cancer	0.00085	0.00129	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000844	0.00279	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000839	0.00278	CbGpPWpGaD
Felbamate—Myalgia—Methotrexate—esophageal cancer	0.000835	0.00127	CcSEcCtD
Felbamate—Chest pain—Methotrexate—esophageal cancer	0.000835	0.00127	CcSEcCtD
Felbamate—Arthralgia—Methotrexate—esophageal cancer	0.000835	0.00127	CcSEcCtD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000828	0.00274	CbGpPWpGaD
Felbamate—Discomfort—Methotrexate—esophageal cancer	0.000825	0.00125	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000817	0.0027	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CFL1—esophageal cancer	0.000816	0.0027	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—ADH7—esophageal cancer	0.00081	0.00268	CbGpPWpGaD
Felbamate—Confusional state—Methotrexate—esophageal cancer	0.000807	0.00122	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000804	0.00266	CbGpPWpGaD
Felbamate—Anaphylactic shock—Methotrexate—esophageal cancer	0.000801	0.00121	CcSEcCtD
Felbamate—Infection—Methotrexate—esophageal cancer	0.000796	0.00121	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—GSTO1—esophageal cancer	0.000795	0.00263	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—SOX2—esophageal cancer	0.000788	0.00261	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTO1—esophageal cancer	0.000784	0.0026	CbGpPWpGaD
Felbamate—Thrombocytopenia—Methotrexate—esophageal cancer	0.000784	0.00119	CcSEcCtD
Felbamate—Hyperhidrosis—Methotrexate—esophageal cancer	0.000774	0.00117	CcSEcCtD
Felbamate—Asthenia—Capecitabine—esophageal cancer	0.000772	0.00117	CcSEcCtD
Felbamate—Anorexia—Methotrexate—esophageal cancer	0.000763	0.00116	CcSEcCtD
Felbamate—Pruritus—Capecitabine—esophageal cancer	0.000761	0.00115	CcSEcCtD
Felbamate—Hypotension—Methotrexate—esophageal cancer	0.000748	0.00113	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000747	0.00247	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TP53—esophageal cancer	0.000747	0.00247	CbGpPWpGaD
Felbamate—Diarrhoea—Capecitabine—esophageal cancer	0.000736	0.00111	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00073	0.00111	CcSEcCtD
Felbamate—Insomnia—Methotrexate—esophageal cancer	0.000724	0.0011	CcSEcCtD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000721	0.00239	CbGpPWpGaD
Felbamate—Paraesthesia—Methotrexate—esophageal cancer	0.000719	0.00109	CcSEcCtD
Felbamate—Dyspnoea—Methotrexate—esophageal cancer	0.000714	0.00108	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000714	0.00236	CbGpPWpGaD
Felbamate—Somnolence—Methotrexate—esophageal cancer	0.000712	0.00108	CcSEcCtD
Felbamate—Dizziness—Capecitabine—esophageal cancer	0.000711	0.00108	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—ADH1B—esophageal cancer	0.00071	0.00235	CbGpPWpGaD
Felbamate—Dyspepsia—Methotrexate—esophageal cancer	0.000705	0.00107	CcSEcCtD
Felbamate—Decreased appetite—Methotrexate—esophageal cancer	0.000696	0.00105	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—ACTB—esophageal cancer	0.000694	0.0023	CbGpPWpGaD
Felbamate—Fatigue—Methotrexate—esophageal cancer	0.00069	0.00105	CcSEcCtD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000687	0.00227	CbGpPWpGaD
Felbamate—Pain—Methotrexate—esophageal cancer	0.000685	0.00104	CcSEcCtD
Felbamate—Vomiting—Capecitabine—esophageal cancer	0.000684	0.00104	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—CTNNA1—esophageal cancer	0.000681	0.00225	CbGpPWpGaD
Felbamate—Rash—Capecitabine—esophageal cancer	0.000678	0.00103	CcSEcCtD
Felbamate—Dermatitis—Capecitabine—esophageal cancer	0.000678	0.00103	CcSEcCtD
Felbamate—Headache—Capecitabine—esophageal cancer	0.000674	0.00102	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000671	0.00222	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP26A1—esophageal cancer	0.00066	0.00218	CbGpPWpGaD
Felbamate—Feeling abnormal—Methotrexate—esophageal cancer	0.00066	0.001	CcSEcCtD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000657	0.00217	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000655	0.00217	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000655	0.000992	CcSEcCtD
Felbamate—CYP2C19—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000651	0.00215	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ABL1—esophageal cancer	0.000651	0.00215	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—ALDH2—esophageal cancer	0.000648	0.00215	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000648	0.00214	CbGpPWpGaD
Felbamate—Nausea—Capecitabine—esophageal cancer	0.000639	0.000968	CcSEcCtD
Felbamate—Urticaria—Methotrexate—esophageal cancer	0.000636	0.000964	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—TP53—esophageal cancer	0.000635	0.0021	CbGpPWpGaD
Felbamate—Abdominal pain—Methotrexate—esophageal cancer	0.000633	0.000959	CcSEcCtD
Felbamate—Body temperature increased—Methotrexate—esophageal cancer	0.000633	0.000959	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—GSTT1—esophageal cancer	0.000617	0.00204	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000616	0.00204	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTO1—esophageal cancer	0.000614	0.00203	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP2A6—esophageal cancer	0.00061	0.00202	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTO1—esophageal cancer	0.000605	0.002	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—PTGS1—esophageal cancer	0.000578	0.00191	CbGpPWpGaD
Felbamate—Asthenia—Methotrexate—esophageal cancer	0.000575	0.00087	CcSEcCtD
Felbamate—Pruritus—Methotrexate—esophageal cancer	0.000567	0.000858	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000566	0.00187	CbGpPWpGaD
Felbamate—Diarrhoea—Methotrexate—esophageal cancer	0.000548	0.00083	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000532	0.00176	CbGpPWpGaD
Felbamate—Dizziness—Methotrexate—esophageal cancer	0.00053	0.000802	CcSEcCtD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000529	0.00175	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000522	0.00173	CbGpPWpGaD
Felbamate—Vomiting—Methotrexate—esophageal cancer	0.000509	0.000771	CcSEcCtD
Felbamate—Rash—Methotrexate—esophageal cancer	0.000505	0.000765	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000505	0.00167	CbGpPWpGaD
Felbamate—Dermatitis—Methotrexate—esophageal cancer	0.000504	0.000764	CcSEcCtD
Felbamate—Headache—Methotrexate—esophageal cancer	0.000502	0.00076	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—ALDH2—esophageal cancer	0.0005	0.00166	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000498	0.00165	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KDR—esophageal cancer	0.000493	0.00163	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP1B1—esophageal cancer	0.000491	0.00163	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000491	0.00163	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000487	0.00161	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000485	0.0016	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MET—esophageal cancer	0.000483	0.0016	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTT1—esophageal cancer	0.000476	0.00157	CbGpPWpGaD
Felbamate—Nausea—Methotrexate—esophageal cancer	0.000476	0.00072	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—CYP2A6—esophageal cancer	0.00047	0.00156	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ABL1—esophageal cancer	0.000464	0.00154	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP19A1—esophageal cancer	0.000462	0.00153	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000459	0.00152	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000456	0.00151	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—SMAD4—esophageal cancer	0.00045	0.00149	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—PTGS1—esophageal cancer	0.000446	0.00148	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000429	0.00142	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000427	0.00141	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000404	0.00134	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000397	0.00131	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000391	0.0013	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.000379	0.00125	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000374	0.00124	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000369	0.00122	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000366	0.00121	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000364	0.0012	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.000356	0.00118	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ERBB2—esophageal cancer	0.000353	0.00117	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KDR—esophageal cancer	0.000352	0.00116	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000352	0.00116	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MET—esophageal cancer	0.000344	0.00114	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NOTCH1—esophageal cancer	0.000332	0.0011	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000301	0.000995	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CREBBP—esophageal cancer	0.000301	0.000995	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000286	0.000947	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000283	0.000936	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000268	0.000887	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ERBB2—esophageal cancer	0.000252	0.000833	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC52A3—esophageal cancer	0.000248	0.000821	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—BLVRB—esophageal cancer	0.000248	0.000821	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000247	0.000817	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—EGFR—esophageal cancer	0.000245	0.000809	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000228	0.000754	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000225	0.000744	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000216	0.000713	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000214	0.000709	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000211	0.0007	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CA1—esophageal cancer	0.000211	0.000698	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC10A2—esophageal cancer	0.000211	0.000698	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EP300—esophageal cancer	0.000205	0.000677	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CA2—esophageal cancer	0.000193	0.000639	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000192	0.000634	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000192	0.000634	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ADH7—esophageal cancer	0.000179	0.000594	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLCE1—esophageal cancer	0.000179	0.000594	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EGFR—esophageal cancer	0.000174	0.000577	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000171	0.000567	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000163	0.000539	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CA1—esophageal cancer	0.000163	0.000539	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ADH1B—esophageal cancer	0.000157	0.000521	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TYMP—esophageal cancer	0.00015	0.000498	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CA2—esophageal cancer	0.000149	0.000493	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP26A1—esophageal cancer	0.000146	0.000484	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000146	0.000482	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALOX15—esophageal cancer	0.000143	0.000472	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.000138	0.000458	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ADH7—esophageal cancer	0.000138	0.000458	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000137	0.000453	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TPI1—esophageal cancer	0.000136	0.00045	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTO1—esophageal cancer	0.000136	0.00045	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALDOB—esophageal cancer	0.00013	0.000432	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GAPDH—esophageal cancer	0.000126	0.000415	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CRABP1—esophageal cancer	0.000124	0.000412	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.000121	0.000402	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GNG7—esophageal cancer	0.000118	0.000392	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TYMP—esophageal cancer	0.000116	0.000384	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000115	0.000381	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000115	0.000381	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000113	0.000374	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALDH2—esophageal cancer	0.000111	0.000367	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALOX15—esophageal cancer	0.00011	0.000364	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTT1—esophageal cancer	0.000105	0.000349	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTO1—esophageal cancer	0.000105	0.000347	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TPI1—esophageal cancer	0.000105	0.000347	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2A6—esophageal cancer	0.000104	0.000345	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALDOB—esophageal cancer	0.000101	0.000333	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ENO1—esophageal cancer	9.88e-05	0.000327	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS1—esophageal cancer	9.88e-05	0.000327	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CA1—esophageal cancer	9.79e-05	0.000324	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.79e-05	0.000324	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PSME2—esophageal cancer	9.74e-05	0.000322	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PSME1—esophageal cancer	9.74e-05	0.000322	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GAPDH—esophageal cancer	9.69e-05	0.00032	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CRABP1—esophageal cancer	9.6e-05	0.000318	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GNG7—esophageal cancer	9.13e-05	0.000302	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CA2—esophageal cancer	8.96e-05	0.000296	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALDH2—esophageal cancer	8.56e-05	0.000283	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1B1—esophageal cancer	8.4e-05	0.000278	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.33e-05	0.000276	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ADH7—esophageal cancer	8.33e-05	0.000276	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTT1—esophageal cancer	8.14e-05	0.000269	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2A6—esophageal cancer	8.04e-05	0.000266	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.01e-05	0.000265	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP19A1—esophageal cancer	7.9e-05	0.000261	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS1—esophageal cancer	7.63e-05	0.000252	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ENO1—esophageal cancer	7.63e-05	0.000252	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PSME2—esophageal cancer	7.51e-05	0.000249	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PSME1—esophageal cancer	7.51e-05	0.000249	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.3e-05	0.000242	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HMOX1—esophageal cancer	7.21e-05	0.000239	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TYMP—esophageal cancer	6.98e-05	0.000231	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCB1—esophageal cancer	6.92e-05	0.000229	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.79e-05	0.000225	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.62e-05	0.000219	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.56e-05	0.000217	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1B1—esophageal cancer	6.48e-05	0.000215	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.31e-05	0.000209	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TPI1—esophageal cancer	6.31e-05	0.000209	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.1e-05	0.000202	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.05e-05	0.0002	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.82e-05	0.000193	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.77e-05	0.000191	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HMOX1—esophageal cancer	5.56e-05	0.000184	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GNG7—esophageal cancer	5.49e-05	0.000182	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.46e-05	0.000181	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.34e-05	0.000177	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.14e-05	0.00017	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.89e-05	0.000162	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.84e-05	0.00016	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CREBBP—esophageal cancer	4.63e-05	0.000153	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ENO1—esophageal cancer	4.59e-05	0.000152	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.59e-05	0.000152	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PSME2—esophageal cancer	4.52e-05	0.00015	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PSME1—esophageal cancer	4.52e-05	0.00015	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NOS3—esophageal cancer	4.14e-05	0.000137	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.04e-05	0.000134	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.9e-05	0.000129	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—esophageal cancer	3.79e-05	0.000125	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.67e-05	0.000121	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.57e-05	0.000118	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.35e-05	0.000111	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.21e-05	0.000106	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NOS3—esophageal cancer	3.19e-05	0.000106	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—EP300—esophageal cancer	3.15e-05	0.000104	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.92e-05	9.67e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—EP300—esophageal cancer	2.43e-05	8.04e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—esophageal cancer	2.33e-05	7.71e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.15e-05	7.1e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NOS3—esophageal cancer	1.92e-05	6.36e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.8e-05	5.95e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.76e-05	5.81e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—EP300—esophageal cancer	1.46e-05	4.84e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.08e-05	3.58e-05	CbGpPWpGaD
